nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP2A—polycystic ovary syndrome	0.816	1	CbGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—S100P—polycystic ovary syndrome	0.00813	0.0946	CbGpPWpGaD
Lucanthone—APEX1—embryo—polycystic ovary syndrome	0.00799	0.0814	CbGeAlD
Lucanthone—APEX1—adrenal cortex—polycystic ovary syndrome	0.00655	0.0667	CbGeAlD
Lucanthone—APEX1—endometrium—polycystic ovary syndrome	0.00585	0.0596	CbGeAlD
Lucanthone—APEX1—uterus—polycystic ovary syndrome	0.00539	0.0549	CbGeAlD
Lucanthone—APEX1—pituitary gland—polycystic ovary syndrome	0.00529	0.0539	CbGeAlD
Lucanthone—APEX1—adipose tissue—polycystic ovary syndrome	0.00527	0.0537	CbGeAlD
Lucanthone—APEX1—adrenal gland—polycystic ovary syndrome	0.00473	0.0481	CbGeAlD
Lucanthone—TOP1—adrenal cortex—polycystic ovary syndrome	0.00458	0.0467	CbGeAlD
Lucanthone—APEX1—female gonad—polycystic ovary syndrome	0.00441	0.0449	CbGeAlD
Lucanthone—APEX1—vagina—polycystic ovary syndrome	0.00438	0.0446	CbGeAlD
Lucanthone—TOP1—Circadian rythm related genes—SFTPC—polycystic ovary syndrome	0.00419	0.0488	CbGpPWpGaD
Lucanthone—APEX1—endocrine gland—polycystic ovary syndrome	0.0041	0.0417	CbGeAlD
Lucanthone—TOP1—endometrium—polycystic ovary syndrome	0.00409	0.0417	CbGeAlD
Lucanthone—TOP1—uterus—polycystic ovary syndrome	0.00377	0.0384	CbGeAlD
Lucanthone—TOP1—pituitary gland—polycystic ovary syndrome	0.0037	0.0377	CbGeAlD
Lucanthone—TOP1—adipose tissue—polycystic ovary syndrome	0.00369	0.0376	CbGeAlD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HELLS—polycystic ovary syndrome	0.00356	0.0414	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.00338	0.0393	CbGpPWpGaD
Lucanthone—TOP1—adrenal gland—polycystic ovary syndrome	0.00331	0.0337	CbGeAlD
Lucanthone—TOP1—female gonad—polycystic ovary syndrome	0.00308	0.0314	CbGeAlD
Lucanthone—TOP1—vagina—polycystic ovary syndrome	0.00306	0.0312	CbGeAlD
Lucanthone—TOP2A—endometrium—polycystic ovary syndrome	0.00291	0.0297	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—LMNA—polycystic ovary syndrome	0.00274	0.0319	CbGpPWpGaD
Lucanthone—TOP2A—uterus—polycystic ovary syndrome	0.00268	0.0273	CbGeAlD
Lucanthone—TOP2A—adipose tissue—polycystic ovary syndrome	0.00262	0.0267	CbGeAlD
Lucanthone—TOP2A—G0 and Early G1—CCNE2—polycystic ovary syndrome	0.00257	0.0299	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.00256	0.0298	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—CDC6—polycystic ovary syndrome	0.00241	0.0281	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNFSF10—polycystic ovary syndrome	0.00241	0.0281	CbGpPWpGaD
Lucanthone—TOP2A—adrenal gland—polycystic ovary syndrome	0.00235	0.024	CbGeAlD
Lucanthone—TOP1—Circadian rythm related genes—CLDN4—polycystic ovary syndrome	0.0022	0.0256	CbGpPWpGaD
Lucanthone—TOP2A—female gonad—polycystic ovary syndrome	0.00219	0.0224	CbGeAlD
Lucanthone—TOP2A—vagina—polycystic ovary syndrome	0.00218	0.0222	CbGeAlD
Lucanthone—APEX1—Synthesis of DNA—CDC6—polycystic ovary syndrome	0.00178	0.0207	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.00174	0.0203	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—BAX—polycystic ovary syndrome	0.00174	0.0202	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDC6—polycystic ovary syndrome	0.00167	0.0194	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCNE2—polycystic ovary syndrome	0.00155	0.0181	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDC6—polycystic ovary syndrome	0.00146	0.017	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00144	0.0168	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—SFTPC—polycystic ovary syndrome	0.00131	0.0152	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.00121	0.014	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.00118	0.0137	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—GNAS—polycystic ovary syndrome	0.00113	0.0131	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—polycystic ovary syndrome	0.0011	0.0128	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—BCL2—polycystic ovary syndrome	0.00106	0.0123	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00105	0.0123	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000998	0.0116	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.000958	0.0112	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.000947	0.011	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.00092	0.0107	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.000891	0.0104	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.000863	0.01	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TH—polycystic ovary syndrome	0.000838	0.00975	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RAB2A—polycystic ovary syndrome	0.000823	0.00957	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.000811	0.00944	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.00081	0.00942	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.000784	0.00913	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000776	0.00903	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.000695	0.00809	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—CLDN4—polycystic ovary syndrome	0.000688	0.008	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCNE2—polycystic ovary syndrome	0.000666	0.00775	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000661	0.0077	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000651	0.00758	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NRG1—polycystic ovary syndrome	0.000639	0.00743	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDC6—polycystic ovary syndrome	0.000626	0.00729	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.000554	0.00645	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.000544	0.00633	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000536	0.00624	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000528	0.00615	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000527	0.00613	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000497	0.00578	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RRM2—polycystic ovary syndrome	0.000489	0.00569	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000472	0.0055	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000467	0.00543	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000461	0.00537	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00045	0.00524	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDC6—polycystic ovary syndrome	0.000444	0.00517	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.000425	0.00495	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000421	0.00489	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000403	0.00469	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000388	0.00451	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RAB2A—polycystic ovary syndrome	0.00038	0.00443	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.000377	0.00439	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.000371	0.00431	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000366	0.00426	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RRM2—polycystic ovary syndrome	0.000347	0.00404	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000341	0.00396	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.000329	0.00383	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000328	0.00381	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	0.000326	0.0038	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—LMNA—polycystic ovary syndrome	0.000304	0.00354	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000301	0.00351	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000294	0.00342	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TOP2A—polycystic ovary syndrome	0.000292	0.0034	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.000278	0.00324	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.00027	0.00314	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000263	0.00306	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TH—polycystic ovary syndrome	0.000262	0.00305	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.000245	0.00285	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000244	0.00284	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000243	0.00282	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.00023	0.00267	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000219	0.00254	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000207	0.00241	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000207	0.0024	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDC6—polycystic ovary syndrome	0.000205	0.00239	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000204	0.00237	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.0002	0.00233	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000179	0.00209	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000169	0.00197	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000167	0.00195	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RRM2—polycystic ovary syndrome	0.00016	0.00187	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000157	0.00183	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000151	0.00176	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000146	0.0017	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000144	0.00168	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—LMNA—polycystic ovary syndrome	0.000141	0.00164	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000136	0.00158	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000131	0.00153	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000126	0.00146	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000122	0.00141	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	9.41e-05	0.0011	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	6.25e-05	0.000727	CbGpPWpGaD
